CEO SUMMARY: Here’s an important development in the battle to get the healthcare community to accept new technology for the preparation of Pap smears. Aetna/U.S. Healthcare announced that it would cover the monolayer preparation tests offered by Cytyc and AutoCyte. Aetna’s decision makes it more difficult for other insurers to refuse reimbursement for this test. […]
To access this post, you must purchase The Dark Report.